Gestalt Diagnostics
PrivateLast Round
Series A
Apr 28, 2025
Total Funding Raised
$13.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Gestalt Diagnostics operates in Healthcare & Life Sciences and is based in Spokane, Washington. Its latest recorded funding round was a Series A round in April 2025.
Gestalt Diagnostics is a healthcare technology company that provides an AI-powered, cloud-based digital pathology platform to help pathologists diagnose diseases faster and more efficiently.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Workflow Automation, Cloud Infrastructure
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gestalt Diagnostics Comparables
Compare Gestalt Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Virasoft | 87% | |
| Corista | 87% | |
| Proscia | 87% |
For institutional investors. Book with your work email.
Gestalt Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 28, 2025 | ||||
| Seed | Mar 1, 2021 |
For institutional investors. Book with your work email.
Gestalt Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cowles Ventures | Seed, Series A |
| Tacoma Venture Fund | Seed, Series A |
| Kickstart | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 36% MoM.
- May 19, 2026
Grew 15% QoQ, from 33 to 38 employees.
For institutional investors. Book with your work email.
Gestalt Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gestalt Diagnostics's valuation, stock price, and market status.
Is Gestalt Diagnostics a public or private company?
Gestalt Diagnostics is a private company.
What is the current stock price of Gestalt Diagnostics?
Gestalt Diagnostics is a private company, so its shares have no public market price. Caplight tracks Gestalt Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gestalt Diagnostics worth (valuation)?
Valuation information for Gestalt Diagnostics is not publicly available.
Can I buy Gestalt Diagnostics stock?
Gestalt Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gestalt Diagnostics's last funding round?
Gestalt Diagnostics's most recent funding round was Series A on April 28, 2025.
Who are the main investors in Gestalt Diagnostics?
Key investors in Gestalt Diagnostics include Cowles Ventures, Tacoma Venture Fund, Kickstart.
Will Gestalt Diagnostics IPO soon?
No public IPO plans have been announced for Gestalt Diagnostics.
How can I track Gestalt Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Gestalt Diagnostics's shares on secondary markets.